作者: 懶惰民族 時間: 2025-3-21 22:50 作者: Axillary 時間: 2025-3-22 01:04
https://doi.org/10.1007/978-3-031-47630-3e survival. Allogeneic stem cell transplantation (SCT) is one strategy that has been demonstrated to improve the outcome of high-risk adults with ALL. In this chapter, we will define this high-risk group, discuss indications for transplantation based on biologic risk group, and review current strate作者: Hectic 時間: 2025-3-22 04:44 作者: Peculate 時間: 2025-3-22 08:51 作者: BABY 時間: 2025-3-22 13:24 作者: chemical-peel 時間: 2025-3-22 19:10
Social Behavior Problems in Adolescenceesis. Such cells fabricate the connective tissue scaffolding and produce cytokines, chemokines, and extracellular matrix proteins that regulate hematopoietic homing and proliferation .. There is growing interest in cotransplantation of allogeneic mesenchymal and hematopoietic progenitors to facilita作者: refine 時間: 2025-3-22 22:52 作者: 雄偉 時間: 2025-3-23 05:03
Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Acute Myelogenous Leukemiaresults of allogeneic transplantation for AML, interpreted within the context of the evolving understanding of the molecular biology and cytogenetics of AML, and the implications of these disease-related factors in the treatment and long-term survival in patients with this disease.作者: FILLY 時間: 2025-3-23 08:06
Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemiae survival. Allogeneic stem cell transplantation (SCT) is one strategy that has been demonstrated to improve the outcome of high-risk adults with ALL. In this chapter, we will define this high-risk group, discuss indications for transplantation based on biologic risk group, and review current strate作者: Carcinogenesis 時間: 2025-3-23 11:22
Non-Hodgkin’s Lymphomaal has dramatically changed the composition of total lymphoma mortality. Indeed, Hodgkin’ s disease accounted for nearly 40% of lymphoma deaths in 1950, but now represents less than 7%. The 5-yr survival of patients with NHL is 51%. These significant changes warrant that major efforts be undertaken 作者: 雇傭兵 時間: 2025-3-23 14:05 作者: 未完成 時間: 2025-3-23 18:25 作者: 必死 時間: 2025-3-24 01:20
Mesenchymal Stem Cells in Allogeneic Transplantationesis. Such cells fabricate the connective tissue scaffolding and produce cytokines, chemokines, and extracellular matrix proteins that regulate hematopoietic homing and proliferation .. There is growing interest in cotransplantation of allogeneic mesenchymal and hematopoietic progenitors to facilita作者: WATER 時間: 2025-3-24 04:42 作者: Callus 時間: 2025-3-24 08:51 作者: 愛國者 時間: 2025-3-24 11:09 作者: installment 時間: 2025-3-24 15:25 作者: Encumber 時間: 2025-3-24 19:44 作者: 懶惰民族 時間: 2025-3-25 00:11 作者: 壯麗的去 時間: 2025-3-25 05:35 作者: 異端邪說下 時間: 2025-3-25 07:57 作者: 很像弓] 時間: 2025-3-25 14:05 作者: obstruct 時間: 2025-3-25 19:12
Development as Action in Contextarrow collection. This trend has further accelerated with the publication of a randomized trial suggesting a superior survival for patients where peripheral blood was used as a source of stem cells over the use of bone marrow (.).作者: ETHER 時間: 2025-3-25 21:30
Development as Action in Contexte rapid evolution of HSCT and supportive care, the epidemiology of IFIs continues to evolve and considerable progress has been made in the development of novel therapeutics and strategies for antifungal prevention and treatment.作者: 構(gòu)成 時間: 2025-3-26 01:26 作者: 收到 時間: 2025-3-26 06:57
Industrial Capital and Underdevelopment, of a Bcr-Abl fusion protein, a constitutively active cytoplasmic tyrosine kinase. The Bcr-Abl protein phosphorylates several substrates, which activate multiple signal transduction cascades, thus altering cell growth, differentiation, and apoptosis. These activities result in independence from normal growth constraints (.).作者: CYN 時間: 2025-3-26 10:04
https://doi.org/10.1007/978-981-99-9987-3deaths attributable to multiple myeloma. Multiple myeloma represents slightly over 1% of all malignancies and 13% of all hematologic malignancies. It is predominantly a disease of older people with a median age at diagnosis of 66 yr However, approx 80% of patients are under the age of 70 and 18% are less than 50 yr of age ..作者: 臨時抱佛腳 時間: 2025-3-26 13:51 作者: 時代 時間: 2025-3-26 20:11 作者: 種子 時間: 2025-3-27 00:47
Cytokines in Allogeneic Stem Cell Mobilizationarrow collection. This trend has further accelerated with the publication of a randomized trial suggesting a superior survival for patients where peripheral blood was used as a source of stem cells over the use of bone marrow (.).作者: 值得尊敬 時間: 2025-3-27 02:27 作者: SAGE 時間: 2025-3-27 08:16
https://doi.org/10.1007/978-1-59259-333-0Grading; T cell; blood; cell; cytokines; hematopoietic stem cell; hematopoietic stem cell transplantation; 作者: patriarch 時間: 2025-3-27 12:05 作者: 卜聞 時間: 2025-3-27 14:56 作者: 不發(fā)音 時間: 2025-3-27 18:58 作者: Meditative 時間: 2025-3-27 22:12 作者: LIMIT 時間: 2025-3-28 06:10 作者: milligram 時間: 2025-3-28 07:44
Development and Testing of Hand Exoskeletons thousands of individuals annually. This evolution is the product of laboratory-based investigations, studies using animal models, and especially clinical trials involving human subjects. The following brief account highlights some of the more outstanding contributions, with particular emphasis on t作者: 全國性 時間: 2025-3-28 11:57 作者: 整頓 時間: 2025-3-28 16:42
https://doi.org/10.1007/978-3-031-47630-3 Approximately 25–50% of these patients may enjoy long-term disease-free survival (DFS), and current research efforts are focused on innovative postremission strategies with the goal of improving the overall survival for adults with ALL. The identification of different prognostic groups based on the作者: 好開玩笑 時間: 2025-3-28 20:28 作者: 溝通 時間: 2025-3-28 22:53 作者: 碎石頭 時間: 2025-3-29 04:10 作者: Muscularis 時間: 2025-3-29 07:33
https://doi.org/10.1007/978-981-99-9987-3 NHL, which makes it the fifth leading cause of cancer death in men and the sixth leading cause of cancer death among women .. NHLs represent around 5% of all newly diagnosed cancers and, in contrast with other malignancies that are decreasing in incidence, the overall incidence of NHL has been incr作者: Fibrinogen 時間: 2025-3-29 15:09 作者: 聯(lián)合 時間: 2025-3-29 17:26
https://doi.org/10.1007/978-3-319-90335-4lood (PB) have been successfully utilized in the treatment of high risk or recurrent hematological malignancies, BM failure syndromes, hemoglobinopathies, selected hereditary immunodeficiency states, and inborn errrors of metabolism .. However, a number of limitations exist that impede the successfu作者: aggressor 時間: 2025-3-29 22:42 作者: tolerance 時間: 2025-3-30 00:07 作者: Cpr951 時間: 2025-3-30 04:48
R. K. Silbereisen,P. Noack,K. Eyferthicant potential benefits for the treatment of multiple types of illnesses, as outlined throughout this text. Unfortunately, the majority of patients are not candidates for this approach. This chapter will discuss a shift in the understanding of the requirements for successful allogeneic hematopoieti作者: 良心 時間: 2025-3-30 11:44
Development as Action in Contexttion (HSCT). Depending on the institution and the transplantation protocol, the overall frequency of IFIs in this setting ranges from 10–25%, and crude mortality exceeds 70% and is close to 100% in patients with disseminated disease or persistent deficiencies in host defenses (.). Coinciding with th作者: fatuity 時間: 2025-3-30 13:08 作者: stress-test 時間: 2025-3-30 19:35
Hematopoietic Stem Cell Transplantation thousands of individuals annually. This evolution is the product of laboratory-based investigations, studies using animal models, and especially clinical trials involving human subjects. The following brief account highlights some of the more outstanding contributions, with particular emphasis on t作者: 頭腦冷靜 時間: 2025-3-30 21:48 作者: 格子架 時間: 2025-3-31 01:24 作者: ambivalence 時間: 2025-3-31 07:45
